 | • レポートコード：MRC308GR11503 • 出版社/出版日：GlobalInfoResearch / 2023年8月 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（2-3営業日） • 産業分類：医薬品＆ヘルスケア |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
GlobalInfoResearchの最新の調査によると、世界のオキシコドン塩酸徐放性薬剤の市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
このレポートは、世界のオキシコドン塩酸徐放性薬剤市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。
市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。
本レポートの主な目的は次のとおりです。
– 世界および主要国の市場機会の規模を決定するため
– オキシコドン塩酸徐放性薬剤の成長可能性を評価するため
– 各製品および最終用途市場の将来の成長を予測するため
– 市場に影響を与える競争要因を評価するため
オキシコドン塩酸徐放性薬剤市場は種類と用途によって区分されます。2018年～2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。
種類別セグメント
・徐放性錠剤、徐放性カプセル
用途別セグメント
・病院、クリニック
主要な市場プレーヤー
・PURDUE PHARMA LP、Teva Pharmaceutical Industries Ltd、Epic Pharma, LLC、Mylan、Amneal Pharmaceuticals, Inc.（Impax）、Lifeon Pharmaceutical、Humanwell Healthcare、Mallinckrodt Pharmaceuticals、Pfizer
地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）
本調査レポートの内容は計15章あります。
・第1章では、オキシコドン塩酸徐放性薬剤製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なオキシコドン塩酸徐放性薬剤メーカーの企業概要、2019年～2022年までのオキシコドン塩酸徐放性薬剤の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なオキシコドン塩酸徐放性薬剤メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年～2029年までの地域別オキシコドン塩酸徐放性薬剤の販売量、売上、成長性を示しています。
・第5、6章では、2018年～2029年までのオキシコドン塩酸徐放性薬剤の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域でのオキシコドン塩酸徐放性薬剤市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、およびオキシコドン塩酸徐放性薬剤の産業チェーンを掲載しています。
・第14、15章では、オキシコドン塩酸徐放性薬剤の販売チャネル、販売業者、顧客、調査結果について説明します。
***** 目次(一部) *****
・市場概要
– オキシコドン塩酸徐放性薬剤の概要
– 種類別分析（2018年vs2022年vs2029年）：徐放性錠剤、徐放性カプセル
– 用途別分析（2018年vs2022年vs2029年）：病院、クリニック
– 世界のオキシコドン塩酸徐放性薬剤市場規模・予測
– 世界のオキシコドン塩酸徐放性薬剤生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– PURDUE PHARMA LP、Teva Pharmaceutical Industries Ltd、Epic Pharma, LLC、Mylan、Amneal Pharmaceuticals, Inc.（Impax）、Lifeon Pharmaceutical、Humanwell Healthcare、Mallinckrodt Pharmaceuticals、Pfizer
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・種類別分析2018年-2029年：徐放性錠剤、徐放性カプセル
・用途別分析2018年-2029年：病院、クリニック
・オキシコドン塩酸徐放性薬剤の北米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・オキシコドン塩酸徐放性薬剤のヨーロッパ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・オキシコドン塩酸徐放性薬剤のアジア市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・オキシコドン塩酸徐放性薬剤の南米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・オキシコドン塩酸徐放性薬剤の中東・アフリカ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析）
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論
1 Market Overview
1.1 Product Overview and Scope of Oxycodone Hydrochloride Extended-Release Drug
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Oxycodone Hydrochloride Extended-Release Drug Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Extended-Release Tablets
1.3.3 Extended-Release Capsules
1.4 Market Analysis by Application
1.4.1 Overview: Global Oxycodone Hydrochloride Extended-Release Drug Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Clinic
1.5 Global Oxycodone Hydrochloride Extended-Release Drug Market Size & Forecast
1.5.1 Global Oxycodone Hydrochloride Extended-Release Drug Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Oxycodone Hydrochloride Extended-Release Drug Sales Quantity (2018-2029)
1.5.3 Global Oxycodone Hydrochloride Extended-Release Drug Average Price (2018-2029)
2 Manufacturers Profiles
2.1 PURDUE PHARMA LP
2.1.1 PURDUE PHARMA LP Details
2.1.2 PURDUE PHARMA LP Major Business
2.1.3 PURDUE PHARMA LP Oxycodone Hydrochloride Extended-Release Drug Product and Services
2.1.4 PURDUE PHARMA LP Oxycodone Hydrochloride Extended-Release Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 PURDUE PHARMA LP Recent Developments/Updates
2.2 Teva Pharmaceutical Industries Ltd
2.2.1 Teva Pharmaceutical Industries Ltd Details
2.2.2 Teva Pharmaceutical Industries Ltd Major Business
2.2.3 Teva Pharmaceutical Industries Ltd Oxycodone Hydrochloride Extended-Release Drug Product and Services
2.2.4 Teva Pharmaceutical Industries Ltd Oxycodone Hydrochloride Extended-Release Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Teva Pharmaceutical Industries Ltd Recent Developments/Updates
2.3 Epic Pharma, LLC
2.3.1 Epic Pharma, LLC Details
2.3.2 Epic Pharma, LLC Major Business
2.3.3 Epic Pharma, LLC Oxycodone Hydrochloride Extended-Release Drug Product and Services
2.3.4 Epic Pharma, LLC Oxycodone Hydrochloride Extended-Release Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Epic Pharma, LLC Recent Developments/Updates
2.4 Mylan
2.4.1 Mylan Details
2.4.2 Mylan Major Business
2.4.3 Mylan Oxycodone Hydrochloride Extended-Release Drug Product and Services
2.4.4 Mylan Oxycodone Hydrochloride Extended-Release Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Mylan Recent Developments/Updates
2.5 Amneal Pharmaceuticals, Inc.（Impax）
2.5.1 Amneal Pharmaceuticals, Inc.（Impax） Details
2.5.2 Amneal Pharmaceuticals, Inc.（Impax） Major Business
2.5.3 Amneal Pharmaceuticals, Inc.（Impax） Oxycodone Hydrochloride Extended-Release Drug Product and Services
2.5.4 Amneal Pharmaceuticals, Inc.（Impax） Oxycodone Hydrochloride Extended-Release Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Amneal Pharmaceuticals, Inc.（Impax） Recent Developments/Updates
2.6 Lifeon Pharmaceutical
2.6.1 Lifeon Pharmaceutical Details
2.6.2 Lifeon Pharmaceutical Major Business
2.6.3 Lifeon Pharmaceutical Oxycodone Hydrochloride Extended-Release Drug Product and Services
2.6.4 Lifeon Pharmaceutical Oxycodone Hydrochloride Extended-Release Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Lifeon Pharmaceutical Recent Developments/Updates
2.7 Humanwell Healthcare
2.7.1 Humanwell Healthcare Details
2.7.2 Humanwell Healthcare Major Business
2.7.3 Humanwell Healthcare Oxycodone Hydrochloride Extended-Release Drug Product and Services
2.7.4 Humanwell Healthcare Oxycodone Hydrochloride Extended-Release Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Humanwell Healthcare Recent Developments/Updates
2.8 Mallinckrodt Pharmaceuticals
2.8.1 Mallinckrodt Pharmaceuticals Details
2.8.2 Mallinckrodt Pharmaceuticals Major Business
2.8.3 Mallinckrodt Pharmaceuticals Oxycodone Hydrochloride Extended-Release Drug Product and Services
2.8.4 Mallinckrodt Pharmaceuticals Oxycodone Hydrochloride Extended-Release Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Mallinckrodt Pharmaceuticals Recent Developments/Updates
2.9 Pfizer
2.9.1 Pfizer Details
2.9.2 Pfizer Major Business
2.9.3 Pfizer Oxycodone Hydrochloride Extended-Release Drug Product and Services
2.9.4 Pfizer Oxycodone Hydrochloride Extended-Release Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Pfizer Recent Developments/Updates
3 Competitive Environment: Oxycodone Hydrochloride Extended-Release Drug by Manufacturer
3.1 Global Oxycodone Hydrochloride Extended-Release Drug Sales Quantity by Manufacturer (2018-2023)
3.2 Global Oxycodone Hydrochloride Extended-Release Drug Revenue by Manufacturer (2018-2023)
3.3 Global Oxycodone Hydrochloride Extended-Release Drug Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Oxycodone Hydrochloride Extended-Release Drug by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Oxycodone Hydrochloride Extended-Release Drug Manufacturer Market Share in 2022
3.4.2 Top 6 Oxycodone Hydrochloride Extended-Release Drug Manufacturer Market Share in 2022
3.5 Oxycodone Hydrochloride Extended-Release Drug Market: Overall Company Footprint Analysis
3.5.1 Oxycodone Hydrochloride Extended-Release Drug Market: Region Footprint
3.5.2 Oxycodone Hydrochloride Extended-Release Drug Market: Company Product Type Footprint
3.5.3 Oxycodone Hydrochloride Extended-Release Drug Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Oxycodone Hydrochloride Extended-Release Drug Market Size by Region
4.1.1 Global Oxycodone Hydrochloride Extended-Release Drug Sales Quantity by Region (2018-2029)
4.1.2 Global Oxycodone Hydrochloride Extended-Release Drug Consumption Value by Region (2018-2029)
4.1.3 Global Oxycodone Hydrochloride Extended-Release Drug Average Price by Region (2018-2029)
4.2 North America Oxycodone Hydrochloride Extended-Release Drug Consumption Value (2018-2029)
4.3 Europe Oxycodone Hydrochloride Extended-Release Drug Consumption Value (2018-2029)
4.4 Asia-Pacific Oxycodone Hydrochloride Extended-Release Drug Consumption Value (2018-2029)
4.5 South America Oxycodone Hydrochloride Extended-Release Drug Consumption Value (2018-2029)
4.6 Middle East and Africa Oxycodone Hydrochloride Extended-Release Drug Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Oxycodone Hydrochloride Extended-Release Drug Sales Quantity by Type (2018-2029)
5.2 Global Oxycodone Hydrochloride Extended-Release Drug Consumption Value by Type (2018-2029)
5.3 Global Oxycodone Hydrochloride Extended-Release Drug Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Oxycodone Hydrochloride Extended-Release Drug Sales Quantity by Application (2018-2029)
6.2 Global Oxycodone Hydrochloride Extended-Release Drug Consumption Value by Application (2018-2029)
6.3 Global Oxycodone Hydrochloride Extended-Release Drug Average Price by Application (2018-2029)
7 North America
7.1 North America Oxycodone Hydrochloride Extended-Release Drug Sales Quantity by Type (2018-2029)
7.2 North America Oxycodone Hydrochloride Extended-Release Drug Sales Quantity by Application (2018-2029)
7.3 North America Oxycodone Hydrochloride Extended-Release Drug Market Size by Country
7.3.1 North America Oxycodone Hydrochloride Extended-Release Drug Sales Quantity by Country (2018-2029)
7.3.2 North America Oxycodone Hydrochloride Extended-Release Drug Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Oxycodone Hydrochloride Extended-Release Drug Sales Quantity by Type (2018-2029)
8.2 Europe Oxycodone Hydrochloride Extended-Release Drug Sales Quantity by Application (2018-2029)
8.3 Europe Oxycodone Hydrochloride Extended-Release Drug Market Size by Country
8.3.1 Europe Oxycodone Hydrochloride Extended-Release Drug Sales Quantity by Country (2018-2029)
8.3.2 Europe Oxycodone Hydrochloride Extended-Release Drug Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Oxycodone Hydrochloride Extended-Release Drug Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Oxycodone Hydrochloride Extended-Release Drug Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Oxycodone Hydrochloride Extended-Release Drug Market Size by Region
9.3.1 Asia-Pacific Oxycodone Hydrochloride Extended-Release Drug Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Oxycodone Hydrochloride Extended-Release Drug Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Oxycodone Hydrochloride Extended-Release Drug Sales Quantity by Type (2018-2029)
10.2 South America Oxycodone Hydrochloride Extended-Release Drug Sales Quantity by Application (2018-2029)
10.3 South America Oxycodone Hydrochloride Extended-Release Drug Market Size by Country
10.3.1 South America Oxycodone Hydrochloride Extended-Release Drug Sales Quantity by Country (2018-2029)
10.3.2 South America Oxycodone Hydrochloride Extended-Release Drug Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Oxycodone Hydrochloride Extended-Release Drug Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Oxycodone Hydrochloride Extended-Release Drug Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Oxycodone Hydrochloride Extended-Release Drug Market Size by Country
11.3.1 Middle East & Africa Oxycodone Hydrochloride Extended-Release Drug Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Oxycodone Hydrochloride Extended-Release Drug Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Oxycodone Hydrochloride Extended-Release Drug Market Drivers
12.2 Oxycodone Hydrochloride Extended-Release Drug Market Restraints
12.3 Oxycodone Hydrochloride Extended-Release Drug Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Oxycodone Hydrochloride Extended-Release Drug and Key Manufacturers
13.2 Manufacturing Costs Percentage of Oxycodone Hydrochloride Extended-Release Drug
13.3 Oxycodone Hydrochloride Extended-Release Drug Production Process
13.4 Oxycodone Hydrochloride Extended-Release Drug Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Oxycodone Hydrochloride Extended-Release Drug Typical Distributors
14.3 Oxycodone Hydrochloride Extended-Release Drug Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table 1. Global Oxycodone Hydrochloride Extended-Release Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Oxycodone Hydrochloride Extended-Release Drug Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. PURDUE PHARMA LP Basic Information, Manufacturing Base and Competitors
Table 4. PURDUE PHARMA LP Major Business
Table 5. PURDUE PHARMA LP Oxycodone Hydrochloride Extended-Release Drug Product and Services
Table 6. PURDUE PHARMA LP Oxycodone Hydrochloride Extended-Release Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. PURDUE PHARMA LP Recent Developments/Updates
Table 8. Teva Pharmaceutical Industries Ltd Basic Information, Manufacturing Base and Competitors
Table 9. Teva Pharmaceutical Industries Ltd Major Business
Table 10. Teva Pharmaceutical Industries Ltd Oxycodone Hydrochloride Extended-Release Drug Product and Services
Table 11. Teva Pharmaceutical Industries Ltd Oxycodone Hydrochloride Extended-Release Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Teva Pharmaceutical Industries Ltd Recent Developments/Updates
Table 13. Epic Pharma, LLC Basic Information, Manufacturing Base and Competitors
Table 14. Epic Pharma, LLC Major Business
Table 15. Epic Pharma, LLC Oxycodone Hydrochloride Extended-Release Drug Product and Services
Table 16. Epic Pharma, LLC Oxycodone Hydrochloride Extended-Release Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Epic Pharma, LLC Recent Developments/Updates
Table 18. Mylan Basic Information, Manufacturing Base and Competitors
Table 19. Mylan Major Business
Table 20. Mylan Oxycodone Hydrochloride Extended-Release Drug Product and Services
Table 21. Mylan Oxycodone Hydrochloride Extended-Release Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Mylan Recent Developments/Updates
Table 23. Amneal Pharmaceuticals, Inc.（Impax） Basic Information, Manufacturing Base and Competitors
Table 24. Amneal Pharmaceuticals, Inc.（Impax） Major Business
Table 25. Amneal Pharmaceuticals, Inc.（Impax） Oxycodone Hydrochloride Extended-Release Drug Product and Services
Table 26. Amneal Pharmaceuticals, Inc.（Impax） Oxycodone Hydrochloride Extended-Release Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Amneal Pharmaceuticals, Inc.（Impax） Recent Developments/Updates
Table 28. Lifeon Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 29. Lifeon Pharmaceutical Major Business
Table 30. Lifeon Pharmaceutical Oxycodone Hydrochloride Extended-Release Drug Product and Services
Table 31. Lifeon Pharmaceutical Oxycodone Hydrochloride Extended-Release Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Lifeon Pharmaceutical Recent Developments/Updates
Table 33. Humanwell Healthcare Basic Information, Manufacturing Base and Competitors
Table 34. Humanwell Healthcare Major Business
Table 35. Humanwell Healthcare Oxycodone Hydrochloride Extended-Release Drug Product and Services
Table 36. Humanwell Healthcare Oxycodone Hydrochloride Extended-Release Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Humanwell Healthcare Recent Developments/Updates
Table 38. Mallinckrodt Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 39. Mallinckrodt Pharmaceuticals Major Business
Table 40. Mallinckrodt Pharmaceuticals Oxycodone Hydrochloride Extended-Release Drug Product and Services
Table 41. Mallinckrodt Pharmaceuticals Oxycodone Hydrochloride Extended-Release Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Mallinckrodt Pharmaceuticals Recent Developments/Updates
Table 43. Pfizer Basic Information, Manufacturing Base and Competitors
Table 44. Pfizer Major Business
Table 45. Pfizer Oxycodone Hydrochloride Extended-Release Drug Product and Services
Table 46. Pfizer Oxycodone Hydrochloride Extended-Release Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Pfizer Recent Developments/Updates
Table 48. Global Oxycodone Hydrochloride Extended-Release Drug Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 49. Global Oxycodone Hydrochloride Extended-Release Drug Revenue by Manufacturer (2018-2023) & (USD Million)
Table 50. Global Oxycodone Hydrochloride Extended-Release Drug Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 51. Market Position of Manufacturers in Oxycodone Hydrochloride Extended-Release Drug, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 52. Head Office and Oxycodone Hydrochloride Extended-Release Drug Production Site of Key Manufacturer
Table 53. Oxycodone Hydrochloride Extended-Release Drug Market: Company Product Type Footprint
Table 54. Oxycodone Hydrochloride Extended-Release Drug Market: Company Product Application Footprint
Table 55. Oxycodone Hydrochloride Extended-Release Drug New Market Entrants and Barriers to Market Entry
Table 56. Oxycodone Hydrochloride Extended-Release Drug Mergers, Acquisition, Agreements, and Collaborations
Table 57. Global Oxycodone Hydrochloride Extended-Release Drug Sales Quantity by Region (2018-2023) & (K Units)
Table 58. Global Oxycodone Hydrochloride Extended-Release Drug Sales Quantity by Region (2024-2029) & (K Units)
Table 59. Global Oxycodone Hydrochloride Extended-Release Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 60. Global Oxycodone Hydrochloride Extended-Release Drug Consumption Value by Region (2024-2029) & (USD Million)
Table 61. Global Oxycodone Hydrochloride Extended-Release Drug Average Price by Region (2018-2023) & (US$/Unit)
Table 62. Global Oxycodone Hydrochloride Extended-Release Drug Average Price by Region (2024-2029) & (US$/Unit)
Table 63. Global Oxycodone Hydrochloride Extended-Release Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 64. Global Oxycodone Hydrochloride Extended-Release Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 65. Global Oxycodone Hydrochloride Extended-Release Drug Consumption Value by Type (2018-2023) & (USD Million)
Table 66. Global Oxycodone Hydrochloride Extended-Release Drug Consumption Value by Type (2024-2029) & (USD Million)
Table 67. Global Oxycodone Hydrochloride Extended-Release Drug Average Price by Type (2018-2023) & (US$/Unit)
Table 68. Global Oxycodone Hydrochloride Extended-Release Drug Average Price by Type (2024-2029) & (US$/Unit)
Table 69. Global Oxycodone Hydrochloride Extended-Release Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 70. Global Oxycodone Hydrochloride Extended-Release Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 71. Global Oxycodone Hydrochloride Extended-Release Drug Consumption Value by Application (2018-2023) & (USD Million)
Table 72. Global Oxycodone Hydrochloride Extended-Release Drug Consumption Value by Application (2024-2029) & (USD Million)
Table 73. Global Oxycodone Hydrochloride Extended-Release Drug Average Price by Application (2018-2023) & (US$/Unit)
Table 74. Global Oxycodone Hydrochloride Extended-Release Drug Average Price by Application (2024-2029) & (US$/Unit)
Table 75. North America Oxycodone Hydrochloride Extended-Release Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 76. North America Oxycodone Hydrochloride Extended-Release Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 77. North America Oxycodone Hydrochloride Extended-Release Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 78. North America Oxycodone Hydrochloride Extended-Release Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 79. North America Oxycodone Hydrochloride Extended-Release Drug Sales Quantity by Country (2018-2023) & (K Units)
Table 80. North America Oxycodone Hydrochloride Extended-Release Drug Sales Quantity by Country (2024-2029) & (K Units)
Table 81. North America Oxycodone Hydrochloride Extended-Release Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 82. North America Oxycodone Hydrochloride Extended-Release Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 83. Europe Oxycodone Hydrochloride Extended-Release Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 84. Europe Oxycodone Hydrochloride Extended-Release Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 85. Europe Oxycodone Hydrochloride Extended-Release Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 86. Europe Oxycodone Hydrochloride Extended-Release Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 87. Europe Oxycodone Hydrochloride Extended-Release Drug Sales Quantity by Country (2018-2023) & (K Units)
Table 88. Europe Oxycodone Hydrochloride Extended-Release Drug Sales Quantity by Country (2024-2029) & (K Units)
Table 89. Europe Oxycodone Hydrochloride Extended-Release Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 90. Europe Oxycodone Hydrochloride Extended-Release Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 91. Asia-Pacific Oxycodone Hydrochloride Extended-Release Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 92. Asia-Pacific Oxycodone Hydrochloride Extended-Release Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 93. Asia-Pacific Oxycodone Hydrochloride Extended-Release Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 94. Asia-Pacific Oxycodone Hydrochloride Extended-Release Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 95. Asia-Pacific Oxycodone Hydrochloride Extended-Release Drug Sales Quantity by Region (2018-2023) & (K Units)
Table 96. Asia-Pacific Oxycodone Hydrochloride Extended-Release Drug Sales Quantity by Region (2024-2029) & (K Units)
Table 97. Asia-Pacific Oxycodone Hydrochloride Extended-Release Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 98. Asia-Pacific Oxycodone Hydrochloride Extended-Release Drug Consumption Value by Region (2024-2029) & (USD Million)
Table 99. South America Oxycodone Hydrochloride Extended-Release Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 100. South America Oxycodone Hydrochloride Extended-Release Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 101. South America Oxycodone Hydrochloride Extended-Release Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 102. South America Oxycodone Hydrochloride Extended-Release Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 103. South America Oxycodone Hydrochloride Extended-Release Drug Sales Quantity by Country (2018-2023) & (K Units)
Table 104. South America Oxycodone Hydrochloride Extended-Release Drug Sales Quantity by Country (2024-2029) & (K Units)
Table 105. South America Oxycodone Hydrochloride Extended-Release Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 106. South America Oxycodone Hydrochloride Extended-Release Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 107. Middle East & Africa Oxycodone Hydrochloride Extended-Release Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 108. Middle East & Africa Oxycodone Hydrochloride Extended-Release Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 109. Middle East & Africa Oxycodone Hydrochloride Extended-Release Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 110. Middle East & Africa Oxycodone Hydrochloride Extended-Release Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 111. Middle East & Africa Oxycodone Hydrochloride Extended-Release Drug Sales Quantity by Region (2018-2023) & (K Units)
Table 112. Middle East & Africa Oxycodone Hydrochloride Extended-Release Drug Sales Quantity by Region (2024-2029) & (K Units)
Table 113. Middle East & Africa Oxycodone Hydrochloride Extended-Release Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 114. Middle East & Africa Oxycodone Hydrochloride Extended-Release Drug Consumption Value by Region (2024-2029) & (USD Million)
Table 115. Oxycodone Hydrochloride Extended-Release Drug Raw Material
Table 116. Key Manufacturers of Oxycodone Hydrochloride Extended-Release Drug Raw Materials
Table 117. Oxycodone Hydrochloride Extended-Release Drug Typical Distributors
Table 118. Oxycodone Hydrochloride Extended-Release Drug Typical Customers
List of Figures
Figure 1. Oxycodone Hydrochloride Extended-Release Drug Picture
Figure 2. Global Oxycodone Hydrochloride Extended-Release Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Oxycodone Hydrochloride Extended-Release Drug Consumption Value Market Share by Type in 2022
Figure 4. Extended-Release Tablets Examples
Figure 5. Extended-Release Capsules Examples
Figure 6. Global Oxycodone Hydrochloride Extended-Release Drug Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Oxycodone Hydrochloride Extended-Release Drug Consumption Value Market Share by Application in 2022
Figure 8. Hospital Examples
Figure 9. Clinic Examples
Figure 10. Global Oxycodone Hydrochloride Extended-Release Drug Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 11. Global Oxycodone Hydrochloride Extended-Release Drug Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 12. Global Oxycodone Hydrochloride Extended-Release Drug Sales Quantity (2018-2029) & (K Units)
Figure 13. Global Oxycodone Hydrochloride Extended-Release Drug Average Price (2018-2029) & (US$/Unit)
Figure 14. Global Oxycodone Hydrochloride Extended-Release Drug Sales Quantity Market Share by Manufacturer in 2022
Figure 15. Global Oxycodone Hydrochloride Extended-Release Drug Consumption Value Market Share by Manufacturer in 2022
Figure 16. Producer Shipments of Oxycodone Hydrochloride Extended-Release Drug by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 17. Top 3 Oxycodone Hydrochloride Extended-Release Drug Manufacturer (Consumption Value) Market Share in 2022
Figure 18. Top 6 Oxycodone Hydrochloride Extended-Release Drug Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Global Oxycodone Hydrochloride Extended-Release Drug Sales Quantity Market Share by Region (2018-2029)
Figure 20. Global Oxycodone Hydrochloride Extended-Release Drug Consumption Value Market Share by Region (2018-2029)
Figure 21. North America Oxycodone Hydrochloride Extended-Release Drug Consumption Value (2018-2029) & (USD Million)
Figure 22. Europe Oxycodone Hydrochloride Extended-Release Drug Consumption Value (2018-2029) & (USD Million)
Figure 23. Asia-Pacific Oxycodone Hydrochloride Extended-Release Drug Consumption Value (2018-2029) & (USD Million)
Figure 24. South America Oxycodone Hydrochloride Extended-Release Drug Consumption Value (2018-2029) & (USD Million)
Figure 25. Middle East & Africa Oxycodone Hydrochloride Extended-Release Drug Consumption Value (2018-2029) & (USD Million)
Figure 26. Global Oxycodone Hydrochloride Extended-Release Drug Sales Quantity Market Share by Type (2018-2029)
Figure 27. Global Oxycodone Hydrochloride Extended-Release Drug Consumption Value Market Share by Type (2018-2029)
Figure 28. Global Oxycodone Hydrochloride Extended-Release Drug Average Price by Type (2018-2029) & (US$/Unit)
Figure 29. Global Oxycodone Hydrochloride Extended-Release Drug Sales Quantity Market Share by Application (2018-2029)
Figure 30. Global Oxycodone Hydrochloride Extended-Release Drug Consumption Value Market Share by Application (2018-2029)
Figure 31. Global Oxycodone Hydrochloride Extended-Release Drug Average Price by Application (2018-2029) & (US$/Unit)
Figure 32. North America Oxycodone Hydrochloride Extended-Release Drug Sales Quantity Market Share by Type (2018-2029)
Figure 33. North America Oxycodone Hydrochloride Extended-Release Drug Sales Quantity Market Share by Application (2018-2029)
Figure 34. North America Oxycodone Hydrochloride Extended-Release Drug Sales Quantity Market Share by Country (2018-2029)
Figure 35. North America Oxycodone Hydrochloride Extended-Release Drug Consumption Value Market Share by Country (2018-2029)
Figure 36. United States Oxycodone Hydrochloride Extended-Release Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 37. Canada Oxycodone Hydrochloride Extended-Release Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Mexico Oxycodone Hydrochloride Extended-Release Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Europe Oxycodone Hydrochloride Extended-Release Drug Sales Quantity Market Share by Type (2018-2029)
Figure 40. Europe Oxycodone Hydrochloride Extended-Release Drug Sales Quantity Market Share by Application (2018-2029)
Figure 41. Europe Oxycodone Hydrochloride Extended-Release Drug Sales Quantity Market Share by Country (2018-2029)
Figure 42. Europe Oxycodone Hydrochloride Extended-Release Drug Consumption Value Market Share by Country (2018-2029)
Figure 43. Germany Oxycodone Hydrochloride Extended-Release Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. France Oxycodone Hydrochloride Extended-Release Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. United Kingdom Oxycodone Hydrochloride Extended-Release Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. Russia Oxycodone Hydrochloride Extended-Release Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Italy Oxycodone Hydrochloride Extended-Release Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Asia-Pacific Oxycodone Hydrochloride Extended-Release Drug Sales Quantity Market Share by Type (2018-2029)
Figure 49. Asia-Pacific Oxycodone Hydrochloride Extended-Release Drug Sales Quantity Market Share by Application (2018-2029)
Figure 50. Asia-Pacific Oxycodone Hydrochloride Extended-Release Drug Sales Quantity Market Share by Region (2018-2029)
Figure 51. Asia-Pacific Oxycodone Hydrochloride Extended-Release Drug Consumption Value Market Share by Region (2018-2029)
Figure 52. China Oxycodone Hydrochloride Extended-Release Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Japan Oxycodone Hydrochloride Extended-Release Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Korea Oxycodone Hydrochloride Extended-Release Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. India Oxycodone Hydrochloride Extended-Release Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Southeast Asia Oxycodone Hydrochloride Extended-Release Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Australia Oxycodone Hydrochloride Extended-Release Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. South America Oxycodone Hydrochloride Extended-Release Drug Sales Quantity Market Share by Type (2018-2029)
Figure 59. South America Oxycodone Hydrochloride Extended-Release Drug Sales Quantity Market Share by Application (2018-2029)
Figure 60. South America Oxycodone Hydrochloride Extended-Release Drug Sales Quantity Market Share by Country (2018-2029)
Figure 61. South America Oxycodone Hydrochloride Extended-Release Drug Consumption Value Market Share by Country (2018-2029)
Figure 62. Brazil Oxycodone Hydrochloride Extended-Release Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. Argentina Oxycodone Hydrochloride Extended-Release Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Middle East & Africa Oxycodone Hydrochloride Extended-Release Drug Sales Quantity Market Share by Type (2018-2029)
Figure 65. Middle East & Africa Oxycodone Hydrochloride Extended-Release Drug Sales Quantity Market Share by Application (2018-2029)
Figure 66. Middle East & Africa Oxycodone Hydrochloride Extended-Release Drug Sales Quantity Market Share by Region (2018-2029)
Figure 67. Middle East & Africa Oxycodone Hydrochloride Extended-Release Drug Consumption Value Market Share by Region (2018-2029)
Figure 68. Turkey Oxycodone Hydrochloride Extended-Release Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Egypt Oxycodone Hydrochloride Extended-Release Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Saudi Arabia Oxycodone Hydrochloride Extended-Release Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. South Africa Oxycodone Hydrochloride Extended-Release Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Oxycodone Hydrochloride Extended-Release Drug Market Drivers
Figure 73. Oxycodone Hydrochloride Extended-Release Drug Market Restraints
Figure 74. Oxycodone Hydrochloride Extended-Release Drug Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Oxycodone Hydrochloride Extended-Release Drug in 2022
Figure 77. Manufacturing Process Analysis of Oxycodone Hydrochloride Extended-Release Drug
Figure 78. Oxycodone Hydrochloride Extended-Release Drug Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source